- Exchanges
- BSE, NSE
- Industry
- Pharmaceuticals
- Issue
- Book building
Emcure Pharmaceuticals IPO
₹1,359.15
+34.84% on listing
Listing-day close · NSE · 10 Jul 2024 · issue price ₹1,008
Emcure Pharmaceuticals’ ₹1,952 crore IPO was priced at ₹1,008 a share. It listed on the NSE on 10 Jul 2024 and closed its first day at ₹1,359.15, up 34.84% on the issue price.
Timeline
- Opens
- Closes
- Allotment
- Refunds
- Shares in demat
- Listing
Issue details
- Issue size
- ₹1,952 Cr
- Fresh issue
- ₹801 Cr
- Offer for sale
- ₹1,151 Cr
- Lot size
- 14 shares
- Minimum investment
- ₹14,112
- Face value
- ₹10
- Registrar
- MUFG Intime India
Subscription
| Category | Shares offered | Times subscribed |
|---|---|---|
| Total | — | 48.13× |
Overall, from the basis of allotment.
Financials and valuation
- Market cap (post-issue)
- ₹19,030 Cr
- P/E (post-issue)
- 36.1
- EPS (post-issue)
- ₹27.95
- Price to book
- 6.2
- ROE
- 16.90%
- ROCE
- 19.37%
- Debt to equity
- 0.67
- PAT margin
- 7.86%
- Promoter holding
- 83.21% → 78.08%
From the offer documents.
Listing
- Listing date
- 10 Jul 2024
- Issue price
- ₹1,008
- Open
- ₹1,325.05
- High
- ₹1,385.00
- Low
- ₹1,325.05
- Close
- ₹1,359.15
Listing day on the NSE. The close was +34.84% on the issue price.
EMCURE PHARMACEUTICALS L share price todayFAQs
When did the Emcure Pharmaceuticals IPO open and close?
It opened on 3 Jul 2024 and closed on 5 Jul 2024.
What was the Emcure Pharmaceuticals IPO price?
The price band was ₹960–1,008 a share. The final issue price was ₹1,008.
What is the lot size and minimum investment?
One lot is 14 shares, ₹14,112 at ₹1,008 a share. Retail investors apply in whole lots.
How much did Emcure Pharmaceuticals raise?
₹1,952 crore: ₹801 crore of new shares and ₹1,151 crore offered by existing shareholders.
How many times was the Emcure Pharmaceuticals IPO subscribed?
48.13 times overall.
How did Emcure Pharmaceuticals list?
It listed on the NSE on 10 Jul 2024 at ₹1,325.05 and closed the day at ₹1,359.15, up 34.84% on the ₹1,008 issue price.
Who is the registrar of the Emcure Pharmaceuticals IPO?
MUFG Intime India handles the allotment, refunds and credit of shares.
For information only. Not investment advice or a research report.
Full disclaimerSee how an IPO fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app